BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Mello CG, Branquinho RT, Oliveira MT, Milagre MM, Saúde-Guimarães DA, Mosqueira VC, Lana Md. Efficacy of Lychnopholide Polymeric Nanocapsules after Oral and Intravenous Administration in Murine Experimental Chagas Disease. Antimicrob Agents Chemother 2016;60:5215-22. [PMID: 27324760 DOI: 10.1128/AAC.00178-16] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Spósito PÁ, Mazzeti AL, de Oliveira Faria C, Urbina JA, Pound-Lana G, Bahia MT, Mosqueira VF. Ravuconazole self-emulsifying delivery system: in vitro activity against Trypanosoma cruzi amastigotes and in vivo toxicity. Int J Nanomedicine 2017;12:3785-99. [PMID: 28553114 DOI: 10.2147/IJN.S133708] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
2 Ferreira LM, Sari MHM, Cervi VF, Prado VC, Nadal JM, Azambuja JH, da Silveira EF, Nogueira CW, Farago PV, Braganhol E, Cruz L. Design of Pegylated-Nanocapsules to Diphenyl Diselenide Administration: In Vitro Evidence of Hemocompatible and Selective Antiglioma Formulation. AAPS PharmSciTech 2020;21:307. [PMID: 33151442 DOI: 10.1208/s12249-020-01845-3] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Mazzeti AL, Capelari-Oliveira P, Bahia MT, Mosqueira VCF. Review on Experimental Treatment Strategies Against Trypanosoma cruzi. J Exp Pharmacol 2021;13:409-32. [PMID: 33833592 DOI: 10.2147/JEP.S267378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Moreira Souza AC, Grabe-Guimarães A, Cruz JDS, Santos-Miranda A, Farah C, Teixeira Oliveira L, Lucas A, Aimond F, Sicard P, Mosqueira VCF, Richard S. Mechanisms of artemether toxicity on single cardiomyocytes and protective effect of nanoencapsulation. Br J Pharmacol 2020;177:4448-63. [PMID: 32608017 DOI: 10.1111/bph.15186] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Karabasz A, Bzowska M, Szczepanowicz K. Biomedical Applications of Multifunctional Polymeric Nanocarriers: A Review of Current Literature. Int J Nanomedicine 2020;15:8673-96. [PMID: 33192061 DOI: 10.2147/IJN.S231477] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Tupinambá Branquinho R, Pound-Lana G, Marques Milagre M, Saúde-Guimarães DA, Vilela JMC, Spangler Andrade M, de Lana M, Mosqueira VCF. Increased Body Exposure to New Anti-Trypanosomal Through Nanoencapsulation. Sci Rep 2017;7:8429. [PMID: 28814794 DOI: 10.1038/s41598-017-08469-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Branquinho RT, Roy J, Farah C, Garcia GM, Aimond F, Le Guennec JY, Saude-Guimarães DA, Grabe-Guimaraes A, Mosqueira VC, de Lana M, Richard S. Biodegradable Polymeric Nanocapsules Prevent Cardiotoxicity of Anti-Trypanosomal Lychnopholide. Sci Rep 2017;7:44998. [PMID: 28349937 DOI: 10.1038/srep44998] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
8 Volpedo G, Costa L, Ryan N, Halsey G, Satoskar A, Oghumu S. Nanoparticulate drug delivery systems for the treatment of neglected tropical protozoan diseases. J Venom Anim Toxins Incl Trop Dis 2019;25:e144118. [PMID: 31130996 DOI: 10.1590/1678-9199-JVATITD-1441-18] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 6.3] [Reference Citation Analysis]
9 Branquinho RT, de Mello CGC, Oliveira MT, Reis LES, Vieira PMA, Saúde-Guimarães DA, Mosqueira VCF, de Lana M. Lychnopholide in Poly(d,l-Lactide)-Block-Polyethylene Glycol Nanocapsules Cures Infection with a Drug-Resistant Trypanosoma cruzi Strain at Acute and Chronic Phases. Antimicrob Agents Chemother 2020;64:e01937-19. [PMID: 31988096 DOI: 10.1128/AAC.01937-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
10 Silva DF, Reis LES, Machado MGC, Dophine DD, de Andrade VR, de Lima WG, Andrade MS, Vilela JMC, Reis AB, Pound-Lana G, Rezende SA, Mosqueira VCF. Repositioning of Tamoxifen in Surface-Modified Nanocapsules as a Promising Oral Treatment for Visceral Leishmaniasis. Pharmaceutics 2021;13:1061. [PMID: 34371752 DOI: 10.3390/pharmaceutics13071061] [Reference Citation Analysis]
11 Fonseca KDS, Perin L, de Paiva NCN, da Silva BC, Duarte THC, Marques FS, Costa GP, Molina I, Correa-Oliveira R, Vieira PMA, Carneiro CM. Benznidazole Treatment: Time- and Dose-Dependence Varies with the Trypanosoma cruzi Strain. Pathogens 2021;10:729. [PMID: 34207764 DOI: 10.3390/pathogens10060729] [Reference Citation Analysis]